GlassScriptPhysician profile
Christopher John Danford
NPI 1790123321
$11,666.09
in general payments reported to CMS, 2019-2025
10 companies · $6,103 in 2025
The $6,103 reported for 2025 was more than what 75% of Transplant Hepatology providers received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2022: $55.62 · 2024: $5,047 · 2025: $6,103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,685 · Travel and Lodging: $1,954 · Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,685.00 |
| Travel and Lodging | $1,954.00 |
| Food and Beverage | $510.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $5,869.00 | 2025 | Iqirvo |
| Madrigal Pharmaceuticals | $5,103.60 | 2024-2025 | Rezdiffra, Resmetirom |
| Abbvie INC. | $185.83 | 2019 | |
| Novo Nordisk INC | $174.33 | 2025 | |
| Intercept Pharmaceuticals, INC. | $150.00 | 2019 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Amgen INC. | $32.06 | 2022 | |
| Mallinckrodt Hospital Products INC. | $23.56 | 2022 | |
| Intuitive Surgical, INC. | $2.71 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Danford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.